Markets & Products
At a glance: Why partner with Evonik for oral drug delivery?
We understand the challenges of oral formulation - from poor solubility and API instability to patient-centric design and regulatory complexity. That’s why we offer more than excipients - we offer solutions.
Partnering with Evonik means:
- Access to the world’s most trusted pharmaceutical polymers
- Support from formulation experts and regulatory specialists
- Integrated CDMO services from concept to commercialization
- Global manufacturing and supply chain security
Whether you're developing a new product or optimizing an existing one, we’re here to help you go further, faster.
Let’s talk about your next oral drug product
Are you working on a formulation challenge? Looking for a reliable partner in oral drug delivery? Our team is ready to support you with technical expertise, tailored solutions, and proven materials.
Get in touch today to explore how Evonik’s functional polymers can help you create more effective oral drug products.
Frequently asked questions (FAQ)
Functional polymers are excipients that do more than bind or fill. They actively control how, when, and where a drug is released in the body. In oral formulations, this means enabling controlled release, targeted delivery, and protection of sensitive APIs.
Controlled release refers to the ability to manage the timing and location of drug release within the gastrointestinal tract. This can improve efficacy, reduce side effects, and enhance patient adherence.
Evonik offers polymers that support:
- Immediate release: For fast therapeutic action
- Delayed release: To bypass the stomach and release in the intestine or colon
- Sustained release: For extended drug activity and reduced dosing frequency
Controlled release is a broader term that includes sustained, delayed, and targeted release. Sustained release specifically refers to maintaining drug levels over time.
Since its introduction in 1954, EUDRAGIT® has helped shape the future of oral drug delivery. With over 23,000 patents and 10,000 scientific publications, it remains the most widely used polymer platform in the industry.
EUDRAGIT® polymers serve a variety of functionalities, such as:
- pH-triggered solubility for enteric coatings
- Permeability control for sustained release
- Taste masking for improved patient experience
Formulators worldwide profit from:
- Proven performance across thousands of formulations
- Tailored functionality for different release profiles
- Regulatory acceptance worldwide
- Compatibility with all major processing technologies
EUDRACAP® functional capsules combine the protective benefits of EUDRAGIT® coatings with the convenience of pre-locked, ready-to-fill formats. They’re ideal for accelerating development and simplifying formulation of sensitive or targeted therapies.
Available formats include:
- EUDRACAP® Enteric – protects APIs from gastric acid
- EUDRACAP® Colon – targets release in the ileo-colonic region
- EUDRACAP® Preclinic – supports animal studies with seamless scale-up
- EUDRACAP® Select – customizable capsules with CDMO support
ANY QUESTIONS? JUST CONTACT US.
"Our global team of experts is ready to support you with all questions around our product and service portfolio for oral drug delivery. Contact us to profit from more than 70 years of application know-how!"
Felix Hofmann
Director Formulation & Application Services
